Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.

Wyman T, Rohrer D, Kirigiti P, Nichols H, Pilcher K, Nilaver G, Machida C.

Gene Ther. 1999 Oct;6(10):1648-60. Review.

2.
3.

Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?

Wierman ME, Xiong X, Kepa JK, Spaulding AJ, Jacobsen BM, Fang Z, Nilaver G, Ojeda SR.

Mol Cell Biol. 1997 Mar;17(3):1652-65.

4.

The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.

Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA.

J Virol. 1996 May;70(5):3207-14.

5.

MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.

Remsen LG, McCormick CI, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellström I, Kroll RA, Neuwelt EA.

AJNR Am J Neuroradiol. 1996 Mar;17(3):411-8.

6.

Genetically modified PC12 brain grafts: survivability and inducible nerve growth factor expression.

Rohrer DC, Nilaver G, Nipper V, Machida CA.

Cell Transplant. 1996 Jan-Feb;5(1):57-68.

PMID:
8665078
7.

Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.

Muldoon LL, Nilaver G, Kroll RA, Pagel MA, Breakefield XO, Chiocca EA, Davidson BL, Weissleder R, Neuwelt EA.

Am J Pathol. 1995 Dec;147(6):1840-51.

8.

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA.

Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9829-33.

9.

Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons.

Rosenmund C, Carr DW, Bergeson SE, Nilaver G, Scott JD, Westbrook GL.

Nature. 1994 Apr 28;368(6474):853-6.

PMID:
8159245
10.

Delivery of virus-sized iron oxide particles to rodent CNS neurons.

Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Roman-Goldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI, et al.

Neurosurgery. 1994 Apr;34(4):777-84.

PMID:
8008188
11.

A-kinase anchoring proteins: a key to selective activation of cAMP-responsive events?

Coghlan VM, Bergeson SE, Langeberg L, Nilaver G, Scott JD.

Mol Cell Biochem. 1993 Nov;127-128:309-19. Review.

PMID:
7935359
12.

Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx.

Kavanagh BD, Halperin EC, Nilaver G.

Cancer. 1993 Jul 1;72(1):299. No abstract available.

PMID:
8508422
13.

Cochlear IgG in the C3H/lpr autoimmune strain mouse.

Wong ML, Young JS, Nilaver G, Morton JI, Trune DR.

Hear Res. 1992 Apr;59(1):93-100.

PMID:
1629052
14.

Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx.

Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver G.

Cancer. 1992 Mar 15;69(6):1315-9.

PMID:
1540868
15.

Tyrosine hydroxylase expression in non-catecholaminergic cells in cerebellar cultures.

Seil FJ, Johnson ML, Nishi R, Nilaver G.

Brain Res. 1992 Jan 8;569(1):164-8.

PMID:
1351772
16.
17.

Generation and characterization of an antiserum directed against neurohypophyseal prohormones.

Verbalis JG, Hoffman GE, Rosenbaum LC, Nilaver G, Loh YP.

J Neuroendocrinol. 1991 Jun 1;3(3):267-72. doi: 10.1111/j.1365-2826.1991.tb00274.x.

PMID:
19215463
18.

Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.

Rosenbaum LC, Neuwelt EA, Van Tol HH, Loh YP, Verbalis JG, Hellström I, Hellström KE, Nilaver G.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9928-32.

19.

Immunological studies with a monoclonal antibody suggest a different conformation of neurophysin in parvicellular neurons of rat hypothalamus.

Nilaver G, Rosenbaum LC, Van Tol HH, Shannon EM, Hagman HM, Zimmerman EA, Neuwelt EA.

Brain Res. 1990 Oct 8;529(1-2):302-8.

PMID:
2282498
20.

Identification of neurophysin immunoreactivity in hypothalamus by a monoclonal antibody to a carcinoma cell surface antigen.

Nilaver G, Rosenbaum LC, Hellström KE, Hellström I, Neuwelt EA.

Neuroendocrinology. 1990 May;51(5):565-71.

PMID:
2112732
21.

Autoimmune etiology for cranial dystonia.

Nilaver G, Whiting S, Nutt JG.

Mov Disord. 1990;5(2):179-80. No abstract available.

PMID:
2325684
22.

Immunoneurology: a serum protein afferent limb to the CNS.

Kozlowski GP, Nilaver G, Zlokovic BV.

Adv Exp Med Biol. 1990;274:345-70. Review. No abstract available.

PMID:
2239432
23.

Detection of low-molecular-weight polypeptides on nitrocellulose with monoclonal antibodies.

Rosenbaum LC, Nilaver G, Hagman HM, Neuwelt EA.

Anal Biochem. 1989 Dec;183(2):250-7.

PMID:
2696385
24.

An antiserum to atrial natriuretic factor (ANF) cross-reacts with neurophysins in the hypothalamo-neurohypophysial system of rat brain.

Nilaver G, Rosenbaum LC, Fukui K, Neuwelt EA, Samson WK, Zimmerman EA, Gibbs DM.

Neuropeptides. 1989 Aug-Sep;14(2):137-44.

PMID:
2530469
25.

Serum anti-myelin antibodies in chronic relapsing experimental allergic encephalomyelitis.

Whitham RH, Nilaver G, Bourdette DN, Seil FJ.

J Neuroimmunol. 1988 May;18(2):155-70.

PMID:
2451682
26.

Characterization of complementary deoxyribonucleic acid for precursor of porcine motilin.

Bond CT, Nilaver G, Godfrey B, Zimmerman EA, Adelman JP.

Mol Endocrinol. 1988 Feb;2(2):175-80.

PMID:
2456453
27.

Heterogeneity of motilin immunoreactivity in mammalian tissue.

Nilaver G, Beinfeld MC, Bond CT, Daikh D, Godfrey B, Adelman JP.

Synapse. 1988;2(3):266-75.

PMID:
3212673
28.

Histochemical identification of a PVN-hindbrain feeding pathway.

Kirchgessner AL, Sclafani A, Nilaver G.

Physiol Behav. 1988;42(6):529-43.

PMID:
2842813
29.

Anatomical basis of thirst and vasopressin secretion.

Zimmerman EA, Ma LY, Nilaver G.

Kidney Int Suppl. 1987 Aug;21:S14-9. Review. No abstract available.

PMID:
3306102
30.
32.

Chemical anatomy of the hypothalamus.

Nilaver G.

Neurol Clin. 1986 Nov;4(4):701-19. Review.

PMID:
2432389
33.

Astrocytes of the human, ovine, rat and guinea-pig brain: an immunocytochemical analysis with GFAP antiserum.

Zang X, Nilaver G.

Chin Med J (Engl). 1986 Sep;99(9):708-12. No abstract available.

PMID:
2433105
34.

Motilin-related immunoreactivity in mammalian adenohypophysis.

Loftus CM, Nilaver G, Beinfeld MC, Post KD.

Neurosurgery. 1986 Aug;19(2):201-4.

PMID:
3748348
35.

Myelination by transplanted fetal and neonatal oligodendrocytes in a dysmyelinating mutant.

Friedman E, Nilaver G, Carmel P, Perlow M, Spatz L, Latov N.

Brain Res. 1986 Jul 16;378(1):142-6.

PMID:
2427154
36.

Elimination of vasopressin analgesia following lesions placed in the rat hypothalamic paraventricular nucleus.

Bodnar RJ, Truesdell LS, Haldar J, Aral IA, Kordower JH, Nilaver G.

Peptides. 1986 Jan-Feb;7(1):111-7.

PMID:
3714529
37.

Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.

Vandenbark AA, Nilaver G, Konat G, Teal P, Offner H.

J Neurosci Res. 1986;16(4):643-56.

PMID:
2432277
38.

Immunocytochemical study of the development of vasotocin/mesotocin in the hypothalamo-hypophysial system of the chick embryo.

Tennyson VM, Nilaver G, Hou-Yu A, Valiquette G, Zimmerman EA.

Cell Tissue Res. 1986;243(1):15-31.

PMID:
2417718
39.

Immunohistochemical localization of TRH in rat CNS: comparison with RIA studies.

Kreider MS, Engber TM, Nilaver G, Zimmerman EA, Winokur A.

Peptides. 1985 Sep-Oct;6(5):997-1000.

PMID:
3936027
40.

Immunocytochemistry of pineal astrocytes: species differences and functional implications.

Zang X, Nilaver G, Stein BM, Fetell MR, Duffy PE.

J Neuropathol Exp Neurol. 1985 Sep;44(5):486-95.

PMID:
3897467
41.

Differential alterations in opioid analgesia following neonatal monosodium glutamate treatment.

Bodnar RJ, Portzline T, Nilaver G.

Brain Res Bull. 1985 Sep;15(3):299-305.

PMID:
2932202
42.

Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.

Bodnar RJ, Truesdell LS, Nilaver G.

Peptides. 1985 Jul-Aug;6(4):621-6.

PMID:
4070021
43.

Hypothalamic oxytocin: a cerebrovascular modulator in man?

Abrams GM, Nilaver G, Recht LR, Haldar J, Zimmerman EA.

Neurology. 1985 Jul;35(7):1046-9.

PMID:
4010943
44.

A study of the substance P innervation of the intermediate zone of the thoracolumbar spinal cord.

Oldfield BJ, Sheppard A, Nilaver G.

J Comp Neurol. 1985 Jun 1;236(1):127-40.

PMID:
2414328
45.

Extrahypothalamic neurohypophysial peptides in the rat central nervous system.

Valiquette G, Haldar J, Abrams GM, Nilaver G, Zimmerman EA.

Brain Res. 1985 Apr 1;331(1):176-9.

PMID:
3986562
46.

Immunocytochemical studies of vasotocin and mesotocin in the hypothalamo-hypophysial system of the chicken.

Tennyson VM, Hou-Yu A, Nilaver G, Zimmerman EA.

Cell Tissue Res. 1985;239(2):279-91.

PMID:
3978693
47.

Pain threshold changes in rats following central injection of beta-endorphin, met-enkephalin, vasopressin or oxytocin antisera.

Bodnar RJ, Nilaver G, Wallace MM, Badillo-Martinez D, Zimmerman EA.

Int J Neurosci. 1984 Oct;24(2):149-60.

PMID:
6094376
48.

The development of motilin-like immunoreactivity in the rat cerebellum and pituitary as determined by radioimmunoassay.

Korchak DM, Nilaver G, Beinfeld MC.

Neurosci Lett. 1984 Aug 10;48(3):267-72.

PMID:
6483286
49.
50.

The distribution and ultrastructure of VIP-immunoreactivity in the central nucleus of the rat amygdala.

Gray TS, Cassell MD, Nilaver G, Zimmerman EA, Williams TH.

Neuroscience. 1984 Feb;11(2):399-408.

PMID:
6717798

Supplemental Content

Loading ...
Support Center